Biorasis

About:

Biorasis commercializes wireless, needle implantable, miniaturized sensor platforms for real-time glucose monitoring.

Top Investors: National Science Foundation, MassChallenge, The Leona M. and Harry B. Helmsley Charitable Trust

Description:

BIORASIS was established in Dec. 2007 with an initial goal to commercialize UCONN’s and OSCI’s wireless, needle-implantable, miniaturized (0.5 x 0.5 x 5 mm) sensor platform for real time, continuous glucose monitoring. In addition to glucose monitoring Biorasis is working towards outfitting its sensor platform to monitor other bio-analytes in the body that are important in other disorders such as cardiovascular, cancer, liver, kidney abnormalities, stroke and epilepsy.

Total Funding Amount:

$3.8M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Mansfield Center, Connecticut, United States

Founded Date:

2007-12-01

Contact Email:

info(AT)bio-orasis.com

Founders:

Faquir Jain, Fotios Papadimitrakopoulos

Number of Employees:

11-50

Last Funding Date:

2018-12-05

IPO Status:

Private

Industries: